Clinical manifestations and treatment outcomes of pyoderma gangrenosum following rituximab exposure: A systematic review.
| Publicado en: | Journal of the American Academy of Dermatology Vol. 87; no. 3; pp. 655 - 657 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | research Journal Article |
| Publicado: |
Elsevier B.V.
Sep2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=158616399&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 158616399 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01909622 1ZF jtl: Journal of the American Academy of Dermatology issn: 01909622 maglogo: N pubinfo: dt: Sep2022 vid: 87 iid: 3 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 158616399 158616399 NLM34942295 158616399 10.1016/j.jaad.2021.12.028 NLM34942295 158616399 ppf: 655 ppct: 2 formats: tig: atl: Clinical manifestations and treatment outcomes of pyoderma gangrenosum following rituximab exposure: A systematic review. aug: au: Croitoru, David Nathanielsz, Nikki Seigel, Kyle Elsawi, Rawaan Sibbald, Cathryn Alavi, Afsaneh Zipursky, Jon Piguet, Vincent affil: Temerty Faculty of Medicine, University of Toronto, Ontario, Canada sug: subj: Pyoderma Gangrenosum Chemically Induced Pyoderma Gangrenosum Drug Therapy Treatment Outcomes Scales pubtype: Academic Journal doctype: research Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|